Non-Invasive Prenatal Testing Market by Test Type and End-users : Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

  • ID: 4531792
  • Report
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 3
The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive prenatal testing (NIPT) market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the non-invasive prenatal testing (NIPT) market on a global level.

In order to give the users of this report a comprehensive view on the non-invasive prenatal testing (NIPT) market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein test type segment and end-user segment are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new technology launch, agreements, partnerships, collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view on the non-invasive prenatal testing (NIPT) market by segmenting the market based on test type, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022. Based on test type the market is segmented into panel 1, panel 2 and panel 3. Key end-users covered under this study include hospitals, diagnostic centers, and maternity clinics. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East Africa with its further bifurcation into major countries including the U.S., Canada, Rest of North America, Germany, U.K., France, Italy, Spain, Russia, Rest of Europe, China, Japan, India, Australia, Rest of Asia Pacific, Brazil, Mexico, Argentina, Rest of Latin America, Saudi Arabia, UAE, Qatar, South Africa and Rest of Middle East and Africa. This segmentation includes demand for veterinary anti-infectives based on individual test type and end-users in all the regions and countries.

The report also includes detailed profiles of end players such Ariosa Diagnostics, Inc., Berry Genomics Co., Ltd, BGI Diagnostics, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom Laboratories, and Quest Diagnostics, Inc.

This report segments the global non-invasive prenatal testing (NIPT) market as follows:

Global Non-Invasive Prenatal Testing (NIPT) Market: Test Type Segment Analysis:
Panel 1
Panel 2
Panel 3

Global Non-Invasive Prenatal Testing (NIPT) Market: End-user Segment Analysis:
Hospitals
Diagnostic Centers
Maternity Clinics

Global Non-Invasive Prenatal Testing (NIPT) Market: Regional Segment Analysis:
North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology

2. Executive Summary
2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, 2016 2022 (USD Million)
2.2. Global Non-Invasive Prenatal Testing (NIPT) Market: Snapshot

3. Non-Invasive Prenatal Testing (NIPT) Market Market Dynamics
3.1. Introduction
3.2. Market Drivers
3.2.1. Global NIPT Market drivers: Impact analysis
3.2.2. Rapid increase in genetic disorders/abnormalities
3.2.3. Increase in global average maternal age and awareness among parents
3.2.4. Expansion of coverage by payers to low and average-risk pregnancies
3.3. Market Restraints
3.3.1. Global NIPT Market restraints: Impact analysis
3.3.2. Records of drug abuse
3.3.3. High test cost
3.3.4. Stringent usage regulations
3.4. Opportunities
3.4.1. Increasing awareness about NIPT tests and improving healthcare facilities in developing countries
3.5. Porters five forces analysis
3.5.1. Bargaining power of suppliers
3.5.2. Bargaining power of buyers
3.5.3. Threat from new entrants
3.5.4. Threat from new substitutes
3.5.5. Degree of competition
3.6. Market attractiveness analysis
3.6.1. Market attractiveness analysis, by species type segment
3.6.2. Market attractiveness analysis, by drug class segment
3.6.3. Market attractiveness analysis, by mode of administration segment
3.6.4. Market attractiveness analysis, by end-user segment
3.6.5. Market attractiveness analysis, by regional segment

4. Global Non-Invasive Prenatal Testing (NIPT) Market Competitive Landscape
4.1. Company Market Share Analysis
4.1.1. Global Non-Invasive Prenatal Testing (NIPT) Market: company market share, 2016
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Test Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research and Development and Regional Expansion
4.3. Price Trend Analysis

5. Global Non-Invasive Prenatal Testing (NIPT) Market Test Type Segment Analysis
5.1. Global non-invasive prenatal testing (NIPT) market: test type overview
5.1.1. Global non-invasive prenatal testing (NIPT) market revenue share, by test type, 2016 and 2022
5.2. Panel 1
5.2.1. Global non-invasive prenatal testing (NIPT) market for panel 1 market, 2016 2022 (USD Million)
5.3. Panel 2
5.3.1. Global non-invasive prenatal testing (NIPT) market for panel 2 market, 2016 2022 (USD Million)
5.4. Panel 3
5.4.1. Global non-invasive prenatal testing (NIPT) market for panel 3 market, 2016 2022 (USD Million)

6. Global Non-Invasive Prenatal Testing (NIPT) Market End-user Segment Analysis
6.1. Global non-invasive prenatal testing (NIPT) market: end-user overview
6.1.1. Global non-invasive prenatal testing (NIPT) market revenue share, by end-user, 2016 and 2022
6.2. Hospitals
6.2.1. Global non-invasive prenatal testing (NIPT) market for hospitals 2016 2022 (USD Million)
6.3. Diagnostic Centers
6.3.1. Global non-invasive prenatal testing (NIPT) market for diagnostic centers, 2016 2022 (USD Million)
6.4. Maternity Clinics
6.4.1. Global non-invasive prenatal testing (NIPT) market for maternity clinics end-users, 2016 2022 (USD Million)

7. Global Non-Invasive Prenatal Testing (NIPT) Market Regional Segment Analysis
7.1. Global non-invasive prenatal testing (NIPT) market: regional overview
7.1.1. Global non-invasive prenatal testing (NIPT) market revenue share, by region, 2016 and 2022
7.2. North America
7.2.1. North America non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.2.2. North America non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.2.3. U.S.
7.2.3.1. U.S. Non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.2.3.2. U.S. Non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.2.4. Canada
7.2.4.1. Canada non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.2.4.2. Canada non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.2.5. Rest of North America
7.2.5.1. Rest of North America non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.2.5.2. Rest of North America non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.3. Europe
7.3.1. Europe non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.3.2. Europe non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.3.3. Germany
7.3.3.1. Germany non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.3.3.2. Germany non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.3.4. U.K.
7.3.4.1. U.K. Non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.3.4.2. U.K. Non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.3.5. France
7.3.5.1. France non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.3.5.2. France non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.3.6. Italy
7.3.6.1. Italy non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.3.6.2. Italy non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.3.7. Spain
7.3.7.1. Spain non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.3.7.2. Spain non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.3.8. Russia
7.3.8.1. Russia non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.3.8.2. Russia non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.3.9. Rest of Europe
7.3.9.1. Rest of Europe non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.3.9.2. Rest of Europe non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.4.2. Asia Pacific non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.4.3. China
7.4.3.1. China non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022(USD Million)
7.4.3.2. China non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.4.4. Japan
7.4.4.1. Japan non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.4.4.2. Japan non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.4.5. India
7.4.5.1. India non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.4.5.2. India non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.4.6. Australia
7.4.6.1. Australia non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.4.6.2. Australia non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.4.7. Rest of Asia Pacific
7.4.7.1. Rest of Asia Pacific non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.4.7.2. Rest of Asia Pacific non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.5. Latin America
7.5.1. Latin America non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.5.2. Latin America non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.5.3. Brazil
7.5.3.1. Brazil non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.5.3.2. Brazil non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.5.4. Mexico
7.5.4.1. Mexico non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.5.4.2. Mexico non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.5.5. Argentina
7.5.5.1. Argentina non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.5.5.2. Argentina non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.5.6. Rest of Latin America
7.5.6.1. Rest of Latin America non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.5.6.2. Rest of Latin America non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.6.2. Middle East and Africa non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.6.3.2. Saudi Arabia non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.6.4. UAE
7.6.4.1. UAE non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.6.4.2. UAE non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.6.5. Qatar
7.6.5.1. Qatar non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.6.5.2. Qatar non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.6.6. South Africa
7.6.6.1. South Africa non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.6.6.2. South Africa non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)
7.6.7. Rest of Middle East and Africa
7.6.7.1. Rest of Middle East and Africa non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)
7.6.7.2. Rest of Middle East and Africa non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

8. Company Profile
8.1. Ariosa Diagnostics, Inc.
8.1.1. Overview
8.1.2. Financials
8.1.3. Test portfolio
8.1.4. Business strategy
8.1.5. Recent developments
8.2. Berry Genomics Co., Ltd.
8.2.1. Overview
8.2.2. Financials
8.2.3. Test portfolio
8.2.4. Business strategy
8.2.5. Recent developments
8.3. BGI Diagnostics
8.3.1. Overview
8.3.2. Financials
8.3.3. Test portfolio
8.3.4. Business strategy
8.3.5. Recent developments
8.4. Illumina, Inc.
8.4.1. Overview
8.4.2. Financials
8.4.3. Test portfolio
8.4.4. Business strategy
8.4.5. Recent developments
8.5. LifeCodexx AG
8.5.1. Overview
8.5.2. Financials
8.5.3. Test portfolio
8.5.4. Business strategy
8.5.5. Recent developments
8.6. Natera, Inc.
8.6.1. Overview
8.6.2. Financials
8.6.3. Test portfolio
8.6.4. Business strategy
8.6.5. Recent developments
8.7. Sequenom Laboratories
8.7.1. Overview
8.7.2. Financials
8.7.3. Test portfolio
8.7.4. Business strategy
8.7.5. Recent developments
8.8. Quest Diagnostics, Inc.
8.8.1. Overview
8.8.2. Financials
8.8.3. Test portfolio
8.8.4. Business strategy
8.8.5. Recent developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll